Compare

ENDRA Life Sciences Inc. vs Nuwellis, Inc. vs Neuraxis, Inc vs iTonic Holdings Ltd

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal yearENDRA Life Sciences Inc.
NDRA
Nuwellis, Inc.
NUWE
Neuraxis, Inc
NRXS
iTonic Holdings Ltd
ITOC
Year ended2025-12-312025-12-312025-12-312025-12-31
Revenuen/a$8.27M$3.57M$523.0K
Revenue growth (YoY)n/a-5.4%+32.9%+16.7%
Gross marginn/a62.0%84.2%62.6%
Operating marginn/a-134.3%-219.4%-991.7%
Net marginn/a-211.9%-218.5%-974.7%
Net income-$7.03M-$17.52M-$7.80M-$5.10M
EPS (Diluted)-$8.93-$25.39-$0.95-$0.32
Operating cash flow-$5.18M-$10.81M-$6.43M-$3.23M
Free cash flow-$5.20M-$10.90M-$6.46M-$3.24M
Cash & equivalentsn/a$1.08M$4.97M$1.49M
Total assets$3.85M$6.12M$6.40M$9.10M
Total liabilities$1.59M$3.49M$3.00M$969.8K
Shareholders' equity$2.26M$2.62M$3.40M$6.12M
Return on year-end equity-310.9%-667.7%-229.5%-83.3%
Shares outstanding1.18M1.69M10.65Mn/a

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal yearENDRA Life Sciences Inc.Nuwellis, Inc.Neuraxis, InciTonic Holdings Ltd
Latest$0
Ended 2020-12-31
$8.27M
Ended 2025-12-31
$3.57M
Ended 2025-12-31
$523.0K
Ended 2025-12-31
1 year earlier$0
Ended 2019-12-31
$8.74M
Ended 2024-12-31
$2.69M
Ended 2024-12-31
$448.2K
Ended 2024-12-31
2 years earlier$6.2K
Ended 2018-12-31
$8.86M
Ended 2023-12-31
$2.46M
Ended 2023-12-31
$628.6K
Ended 2023-12-31
3 years earlier$351.6K
Ended 2017-12-31
$8.54M
Ended 2022-12-31
$2.68M
Ended 2022-12-31
$679.8K
Ended 2022-12-31
4 years earlier$515.6K
Ended 2016-12-31
$7.92M
Ended 2021-12-31
n/an/a